Cargando…

Inhibition of N‐myc expression sensitizes human neuroblastoma IMR‐32 cells expressing caspase‐8 to TRAIL

OBJECTIVES: This study aims to explore the roles of N‐myc and caspase‐8 in TRAIL‐resistant IMR‐32 cells which exhibit MYCN oncogene amplification and lack caspase‐8 expression. MATERIALS AND METHODS: We established N‐myc–downregulated IMR‐32 cells using shRNA lentiviral particles targeting N‐myc and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Myoung Woo, Kim, Dae Seong, Kim, Hye Ryung, Park, Hyun Jin, Lee, Ji Won, Sung, Ki Woong, Koo, Hong Hoe, Yoo, Keon Hee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536445/ https://www.ncbi.nlm.nih.gov/pubmed/30724400 http://dx.doi.org/10.1111/cpr.12577

Ejemplares similares

Etoposide sensitizes neuroblastoma cells expressing caspase 8 to TRAIL
por: Kim, Hye Ryung, et al.
Publicado: (2012)

CDDO and ATRA Instigate Differentiation of IMR32 Human Neuroblastoma Cells
por: Chaudhari, Namrata, et al.
Publicado: (2017)

Lactoferrin inhibits the proliferation of IMR‑32 neuroblastoma cells even under X‑rays
por: Kato, Shinya
Publicado: (2023)

The Involvement of Microtubules and Actin during the Infection of Japanese Encephalitis Virus in Neuroblastoma Cell Line, IMR32
por: Henry Sum, Magdline Sia
Publicado: (2015)

Tumorigenic proteins upregulated in the MYCN-amplified IMR-32 human neuroblastoma cells promote proliferation and migration
por: Zaatiti, Hayat, et al.
Publicado: (2018)

Imidazopyridazine Acetylcholinesterase Inhibitors Display Potent Anti-Proliferative Effects in the Human Neuroblastoma Cell-Line, IMR-32
por: Sharma, Rakesh Kumar, et al.
Publicado: (2021)

GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells
por: Filatova, Elena, et al.
Publicado: (2017)

Differential Clinical Significance of Neurotrophin-3 Expression according to MYCN Amplification and TrkC Expression in Neuroblastoma
por: Seo, Eunseop, et al.
Publicado: (2019)

Human bone marrow-derived mesenchymal stem cell gene expression patterns vary with culture conditions
por: Lee, Myoung Woo, et al.
Publicado: (2013)

Functional Properties of Human Nicotinic Achrs Expressed by Imr-32 Neuroblastoma Cells Resemble Those of α3β4 Achrs Expressed in Permanently Transfected Hek Cells
por: Nelson, Mark E., et al.
Publicado: (2001)

Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma
por: Lee, Eunjin, et al.
Publicado: (2020)

DNA Ligase 4 Contributes to Cell Proliferation against DNA-PK Inhibition in MYCN-Amplified Neuroblastoma IMR32 Cells
por: Ando, Kiyohiro, et al.
Publicado: (2023)

Enzymatic Spermine Metabolites Induce Apoptosis Associated with Increase of p53, caspase-3 and miR-34a in Both Neuroblastoma Cells, SJNKP and the N-Myc-Amplified Form IMR5
por: Kanamori, Yuta, et al.
Publicado: (2021)

Strategies to improve the immunosuppressive properties of human mesenchymal stem cells
por: Lee, Myoung Woo, et al.
Publicado: (2015)

Excellent treatment outcomes in children younger than 18 months with stage 4 MYCN nonamplified neuroblastoma
por: Kim, Chiwoo, et al.
Publicado: (2018)

Neuroblastoma Originating from Extra-abdominal Sites: Association with Favorable Clinical and Biological Features
por: Sung, Ki Woong, et al.
Publicado: (2009)

Mesenchymal stem cells in suppression or progression of hematologic malignancy: current status and challenges
por: Lee, Myoung Woo, et al.
Publicado: (2019)

Clinical Significance of Persistent Tumor in Bone Marrow during Treatment of High-risk Neuroblastoma
por: Choi, Young Bae, et al.
Publicado: (2015)

Synthesis and Anticancer Activity of [RuCl(2)(η(6)-arene)(aroylthiourea)] Complexes—High Activity against the Human Neuroblastoma (IMR-32) Cancer Cell Line
por: Swaminathan, Srividya, et al.
Publicado: (2019)

Double high-dose chemotherapy with autologous stem cell transplantation in patients with high-risk neuroblastoma: a pilot study in a single center.
por: Sung, Ki Woong, et al.
Publicado: (2002)

ARID1B alterations identify aggressive tumors in neuroblastoma
por: Lee, Soo Hyun, et al.
Publicado: (2017)

High-dose Chemotherapy and Autologous Stem Cell Rescue in Patients with High-risk Stage 3 Neuroblastoma: 10-Year Experience at a Single Center
por: Suh, Jung Min, et al.
Publicado: (2009)

GD2 ganglioside-binding antibody 14G2a and specific aurora A kinase inhibitor MK-5108 induce autophagy in IMR-32 neuroblastoma cells
por: Durbas, Małgorzata, et al.
Publicado: (2018)

Nardostachys jatamansi Root Extract Modulates the Growth of IMR-32 and SK-N-MC Neuroblastoma Cell Lines Through MYCN Mediated Regulation of MDM2 and p53
por: Suryavanshi, Snehal, et al.
Publicado: (2017)

Gene Expression Profiles of Human Adipose Tissue-Derived Mesenchymal Stem Cells Are Modified by Cell Culture Density
por: Kim, Dae Seong, et al.
Publicado: (2014)

Clinical Significance of Tyrosine Hydroxylase mRNA Transcripts in Peripheral Blood at Diagnosis in Patients with Neuroblastoma
por: Lee, Na Hee, et al.
Publicado: (2016)

Enhanced Immunosuppressive Properties of Human Mesenchymal Stem Cells Primed by Interferon-γ
por: Kim, Dae Seong, et al.
Publicado: (2018)

Clinical significance of germline telomere length and associated genetic factors in patients with neuroblastoma
por: Bae, Joon Seol, et al.
Publicado: (2022)

Genome-Wide Association Study for the Identification of Novel Genetic Variants Associated with the Risk of Neuroblastoma in Korean Children
por: Bae, Joon Seol, et al.
Publicado: (2020)

Absolute Neutrophil Count after the First Chemotherapy Cycle as a Surrogate Marker for Treatment Outcomes in Patients with Neuroblastoma
por: Lee, Ji Won, et al.
Publicado: (2022)

Clinical Significance of Segmental Chromosomal Aberrations in Patients with Neuroblastoma: First Report in Korean Population
por: Lim, Hana, et al.
Publicado: (2020)

DNA Microarray Highlights Nrf2-Mediated Neuron Protection Targeted by Wasabi-Derived Isothiocyanates in IMR-32 Cells
por: Trio, Phoebe Zapanta, et al.
Publicado: (2016)

Iron Overload during Follow-up after Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with High-Risk Neuroblastoma
por: Bae, Soo Jin, et al.
Publicado: (2012)

MYC Rearrangement Involving a Novel Non-immunoglobulin Chromosomal Locus in Precursor B-cell Acute Lymphoblastic Leukemia
por: Seo, Ja-Young, et al.
Publicado: (2012)

siRNA against presenilin 1 (PS1) down regulates amyloid β42 production in IMR-32 cells
por: Kandimalla, Ramesh JL, et al.
Publicado: (2012)

An insert-based enzymatic cell culture system to rapidly and reversibly induce hypoxia: investigations of hypoxia-induced cell damage, protein expression and phosphorylation in neuronal IMR-32 cells
por: Huang, Ying, et al.
Publicado: (2013)

Incorporation of high-dose (131)I-metaiodobenzylguanidine treatment into tandem high-dose chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma: results of the SMC NB-2009 study
por: Lee, Ji Won, et al.
Publicado: (2017)

Clinical relevance of TRKA expression on neuroblastoma: comparison with N-MYC amplification and CD44 expression.
por: Combaret, V., et al.
Publicado: (1997)

Extracellular matrix rigidity modulates neuroblastoma cell differentiation and N-myc expression
por: Lam, Wilbur A, et al.
Publicado: (2010)

Isoxazole compound ML327 blocks MYC expression and tumor formation in neuroblastoma
por: Rellinger, Eric J., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_go3gi8ge1u3tsufuq95701khjd